Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Healthcare News Netherlands.
Europe Equine Healthcare Market Predicted to Grow Expeditiously: to Surpass US$ 1,959.48 Million | CAGR 6.3% By 2032
EIN Presswire
·
October 31, 2024
The escalating existence of equine illnesses in Europe is driving the demand for Europe equine healthcare market. NEW YORK CITY, NY, UNITED STATES, October 31, 2024 /EINPresswire.com/ -- 𝐓𝐡𝐞 𝐄𝐮𝐫𝐨𝐩𝐞 𝐞𝐪𝐮𝐢𝐧𝐞 𝐡𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐫𝐞𝐩𝐨𝐫𝐭 𝐚𝐬𝐬𝐞𝐬𝐬𝐞𝐬 𝐭𝐡𝐞...
Nuclear Medicine Market Analysis 2024: Size, Share & Growth Report | CAGR 11.3%
EIN Presswire
·
October 29, 2024
The global nuclear medicine market, valued at $5.5 billion in 2023, is expected to grow at an 11.3% CAGR, reaching $16.1 billion by 2033. WILMINGTON, DE, UNITED STATES, October 29, 2024 /EINPresswire.com/ -- Allied Market Research has recently...
Khondrion announces publication in Brain of integrated Phase 2b program demonstrating disease-modifying potential of sonlicromanol in primary mitochondrial disease
GlobeNewswire, Inc.
·
November 7, 2024
NIJMEGEN, the Netherlands – 7 November 2024: Khondrion, a clinical stage biopharmaceutical company discovering and developing therapies targeting primary mitochondrial disease (PMD), today announced the publication of results from its integrated...
Intrinseque Health Expands its Presence in Asia with Enhanced Operations in India
EIN Presswire
·
November 4, 2024
Intrinseque Health is pleased to announce the expansion of its operations in India NEW DELHI, DELHI, INDIA, November 4, 2024 /EINPresswire.com/ -- Intrinseque Health is pleased to announce the expansion of its operations in India, further...
ATNi Launches 5th Global Access to Nutrition Index as Industry and Policy Makers Grapple with Food Polycrisis
GlobeNewswire, Inc.
·
November 7, 2024
UTRECHT, The Netherlands, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Today, ATNi launches the 5th edition of the Global Access to Nutrition Index, the largest yet, assessing the world’s 30 largest food and beverage manufacturers and over 52,000 products,...
Rapid Micro Biosystems to Participate in the Stifel 2024 Healthcare Conference
GlobeNewswire, Inc.
·
November 8, 2024
LEXINGTON, Mass., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient...
[Latest] Global Cell and Gene Therapy Market Size/Share Worth USD 118.63 Billion by 2034 at a 18.79% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
GlobeNewswire, Inc.
·
June 25, 2025
Austin, TX, USA, June 25, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Cell and Gene Therapy Market Size, Trends and Insights By Therapy Type (Cell Theray, Gene Therapy), By Therapeutic Class...
Probiotics in Animal Feed Market: A Growth Driven by Sustainability and Science
GlobeNewswire, Inc.
·
July 10, 2025
Delray Beach, FL, July 10, 2025 (GLOBE NEWSWIRE) -- The global probiotics in animal feed market is on a strong growth path, with projections showing it rising from USD 5.40 billion in 2025 to USD 8.27 billion by 2030, achieving a solid CAGR of...
Health Insurance Technology Market Set for Explosive Growth: Collective Health, Devoted Health
EIN Presswire
·
July 20, 2024
The Financial Institutions Compliance Training market size is estimated to increase by USD at a CAGR of 16.81% by 2030. PUNE, MAHARASHTRA, INDIA, July 20, 2024 /EINPresswire.com/ -- According to HTF Market Intelligence, the Global Health...
Philips enrolls first patient in U.S. clinical trial for innovative integrated single-device to treat peripheral artery disease
GlobeNewswire, Inc.
·
November 4, 2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular Institute of the...
See hummingbirds up close at banding event in northeastern Utah
Utah Division of Wildlife Resources
·
July 1, 2025
Dutch John — As hummingbirds are migrating through Utah this summer, you've most likely witnessed a few eating at a feeder or enjoying some other source of nectar for a quick meal. Join the Utah Division of Wildlife Resources, Ashley National...
Identity and Access Management in Healthcare Market is Expected Grow to US$ 5.57 Billion With 16.9% CAGR From 2024-2032
EIN Presswire
·
October 30, 2024
The growing acquisition of cloud-based solutions is a prominent factor driving identity and access management in the healthcare market. NEW YORK CITY, NY, UNITED STATES, October 30, 2024 /EINPresswire.com/ -- The identity and access management...
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire, Inc.
·
November 1, 2024
NAARDEN, The Netherlands and MIAMI, Nov. 01, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for...
NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter Financial Results
GlobeNewswire, Inc.
·
November 6, 2024
– Topline data from pivotal Phase 3 TANDEM trial now expected in 4Q 2024 due to faster than expected enrollment – – On-track to report topline data from pivotal Phase 3 BROADWAY trial in 4Q 2024 – – Strong balance sheet with $422.7 million in cash...
NewAmsterdam Pharma to Participate in Upcoming Medical and Investor Conferences in November
GlobeNewswire, Inc.
·
October 28, 2024
NAARDEN, The Netherlands and MIAMI, Oct. 28, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for...
VRG Therapeutics Announces Monthly Dosing for Its Kv1.3 Program for the Treatment of Chronic Inflammatory Diseases
EIN Presswire
·
October 18, 2024
VRG Therapeutics reaches monthly dosing for its lead program targeting Kv1.3 for the treatment of atopic dermatitis and other chronic inflammatory diseases. LEIDEN, NETHERLANDS, October 18, 2024 /EINPresswire.com/ -- VRG Therapeutics (VRG Tx), a...
ONWARD® Medical Publishes Closing of Bookbuild Offering
GlobeNewswire, Inc.
·
October 28, 2024
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) EINDHOVEN, the Netherlands, Oct. 28, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD) (the...
Guest article in SDG Knowledge Hub: Harnessing a One Health approach to food systems transformation
Stockholm Environment Institute
·
November 7, 2024
More countries recognize the need to reform their food systems to align with the global heating limits of the Paris Agreement. But doing so could lead to trade-offs that harm public health, animal welfare and ecosystems. SEI Scientist Cleo...
AVer Europe and Charmex Announce a Strategic Distribution Partnership
EIN Presswire
·
July 1, 2025
ROTTERDAM, NETHERLANDS, July 1, 2025 /EINPresswire.com/ -- AVer Information Europe B.V., a leader in video collaboration, ProAV and education technology, is delighted to announce its new partnership with Charmex Internacional S.A.U (“Charmex”),...
VEON’s Jazz Launches FikrFree: An AI-Powered Digital Marketplace to Unlock Affordable Insurance and Healthcare in Pakistan
GlobeNewswire, Inc.
·
October 24, 2024
Amsterdam and Dubai, 24 October 2024: VEON Ltd. (Nasdaq: VEON, Euronext Amsterdam: VEON), a global digital operator (“VEON” or the “Company”), today announces that Jazz, its digital operator in Pakistan, has launched FikrFree, a new AI-powered...